Educators stimulating brains in regional WA
An engaging roadshow will bring neuroscience education to schools and the community in regional Western Australia. The program includes public...
Continue reading
This website may not work correctly in Internet Explorer. We recommend switching to a more secure modern web browser such as Microsoft Edge which is already installed on your computer.
Perron Institute’s Media Centre displays media statements and is the central point of contact for journalists and media outlets seeking expert comments, information about research developments and other information.
All media enquiries should be directed to Perron Institute’s Communications Manager Tennille Kroemer on +61 426 044 223 or tennille.kroemer@perron.uwa.edu.au.
This contact information is for media outlets, journalists and producers only. For all other enquiries, visit the Perron Institute contact page.
An engaging roadshow will bring neuroscience education to schools and the community in regional Western Australia. The program includes public...
Biotechnology company Argenica Therapeutics, which is developing novel treatments to reduce brain tissue death following types of brain injury such...
A trailblazing neuroprotective drug developed in Western Australia to reduce brain tissue death after stroke is proceeding to the next...
Hole in One hopefuls are expected to be out in droves at the Wembley Golf Course on Sunday 15 October...
Enormous effort is being made to find an effective treatment for motor neurone disease (MND), a rare but devastating illness...
In Australia, two in five young people under the age of 24 years currently suffer from a mental health condition....
WA-led international research recently published indicates a pathological link between osteoporosis and the risk of developing Alzheimer’s disease. Findings of...
Argenica Therapeutics, a Western Australian-based biotechnology company developing novel therapeutics to reduce brain tissue death after stroke and other brain...
An innovative new project from Edith Cowan University (ECU), the Perron Institute and Anthologie aims to help improve the health...
A new strand of research planned by WA researchers towards developing a drug for Amyotrophic Lateral Sclerosis (ALS) has attracted...
Western Australian researchers have contributed to an international study which has identified the first genetic marker for multiple sclerosis (MS)...
Research to improve the diagnosis and treatment of the movement disorder, dystonia, has attracted a $100,000 grant from the WA...
Stay up to date with our latest news and announcements.